Fat-1 transgenic cattle as a model to study the function ofω-3 fatty acids

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Guo, Tao ^a,b   Liu, Xin F ^a   Ding, Xiang B ^a   Yang, Fei F ^a   Nie, Yong W ^a   An, Yu J ^b   Guo, Hong ^a  

^a TIANJIN AGRICULTURAL UNIVERSITY   (China)

^b INNER MONGOLIA AGRICULTURAL UNIVERSITY   (China)

Author keywords

3 fatty acids; fat 1; gene expression; gene function; transgenic cattle

Indexed keywords

COMPLEMENTARY DNA; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; ACYL COENZYME A DESATURASE; CAENORHABDITIS ELEGANS PROTEIN; FAT 1 PROTEIN, C ELEGANS; FAT-1 PROTEIN, C ELEGANS; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; FAT 1 GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC DIFFERENCE; GENOMICS; IMMUNITY; INFLAMMATION; LIPID METABOLISM; MALE FERTILITY; NERVE CELL DIFFERENTIATION; NONHUMAN; NUCLEOTIDE SEQUENCE; SIGNAL TRANSDUCTION; TRANSGENE; TRANSGENIC CATTLE; WILD TYPE; ANIMAL; BIOSYNTHESIS; CATTLE; FERTILITY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; NERVOUS SYSTEM; PHYSIOLOGY; TRANSGENIC ANIMAL;

BOS;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CAENORHABDITIS ELEGANS PROTEINS; CATTLE; FATTY ACID DESATURASES; FATTY ACIDS, OMEGA-3; FERTILITY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNITY; INFLAMMATION; LIPID METABOLISM; NERVOUS SYSTEM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECOMBINANT PROTEINS;

EID: 84855174940     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-244     Document Type: Article

References (85)

1. Adenoviral gene transfer of Caenorhabditis elegans n-3 fatty acid desaturase optimizes fatty acid composition in mammalian cells. Kang ZB, Ge Y, Chen Z, Cluette-Brown J, Laposata M, Leaf A, Kang JX, Proc Natl Acad Sci USA 2001 98 7 4050 4054 10.1073/pnas.061040198 11259654 (Pubitemid 32249896)
2. Transgenic fat-1 mouse as a model to study the pathophysiology of cardiovascular, neurological and psychiatric disorders. Das Undurti N, Puskás Lászlá G, Lipids in Health and Disease 2009 8 61 10.1186/1476-511X-8-61 20042103
3. Fat caloric intake and obesity: lifestyle risk factors for breast cancer. Greenwald P, Sherwood K, McDonald SS, J Am Diet Assoc 1997 97 24 30 10.1016/S0002-8223(97)00726-8 9216564 (Pubitemid 27297286)
4. Inuence of n-3 fatty acid supplementation on the endogenous activities of plasma lipoprotein lipase. Harris WS, Lu GP, Rambjor GS, Wålen AI, Ontko JA, Cheng Q, Windsor SL, Am J Clin Nutr 1997 66 254 60 9250102 (Pubitemid 27360322)
5. Triglyceride and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Hodis HN, Mack WJ, Azen SP, Alaupovic P, Pogoda JM, LaBree L, Hemphill LC, Kramsch DM, Blankenhorn DH, Circulation 1994 90 42 49 8026027
6. The role of n-3 polyunsaturated fatty acids in brain: Modulation of rat brain gene expression by dietary n-3 fatty acids. Kitajka K, Puskás LG, Zvara A, Hackler L Jr, Barcelá-Coblijn G, Yeo YK, Farkas T, Proc Natl Acad Sci USA 2002 99 5 2619 2624 10.1073/pnas.042698699 11880617 (Pubitemid 34240510)
7. Polyunsaturated fatty acid regulation of gene transcription: a mechanism to improve energy balance and insulin resistance. Clarke SD, Br J Nutr 2000 83 Suppl 1 59 S66 10889793
8. Dietary polyunsaturated fatty acids and regulation of gene transcription. Jump DB, Curr Opin Lipidol 2002 13 155 164 10.1097/00041433-200204000-00007 11891418 (Pubitemid 34280767)
9. Fatty acid regulation of gene expression: a genomic explanation for the benefits of the Mediterranean diet. Clarke SD, Gasperikova D, Nelson C, Lapillonne A, Heird WC, Ann NY Acad Sci 2002 967 283 298 12079856 (Pubitemid 34721914)
10. Dietary inuence on serum lipids and lipoproteins. Grundy SM, Denke MA, J Lipid Res 1990 31 1149 72 2205699 (Pubitemid 20224714)
11. A decreased n-6/n-3 ratio in the fat-1 mouse is associated with improved glucose tolerance. Smith BK, Holloway GP, Reza-Lopez S, Jeram SM, Kang JX, Ma DW, Appl Physiol Nutr Metab 2010 35 5 699 706 10.1139/H10-066 20962926
12. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity and weight loss. Kelly DE, Goodpaster B, Wing RR, Simoneau JA, Am J Physiol 1999 277 6 pt.1 1130 E1141 10600804
13. Skeletal muscle mitochondrial fat/CD36 content and palmitate oxidation are not decreased in obese women. Holloway GP, Thrush AB, heigenhauser GJ, Tandon NN, Dyck DJ, Bonen A, Spriet LL, Am J Physiol Endocrinol Metab 2007 292 6 1782 89 10.1152/ajpendo.00639.2006 (Pubitemid 47084714)
14. Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induce insulin resistance. Bruce CR, Hoy AJ, Turner N, Watt MJ, Allen TL, Carpenter K, Cooney GJ, Febbraio MA, Kraegen EW, Diabetes 2009 58 3 550 558 19073774
15. Modest PGC-1 overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in subsarcolemmal, not intermyofibrillar, mitochondria. Benton CR, Nickerson JG, Lally J, Han XX, Holloway GP, Glatz JF, Luiken JJ, Graham TE, Heikkila JJ, Bonen A, J Biol Chem 2008 283 7 4228 4240 18079123
16. Eicosapentaenoic acid decreases hepatic synthesis and secretion of triacylglycerol by decreasing the activity of acyl CoA: 1,2-diacylglycerol acyl transferase. Rustan AC, Nossen JO, Christiansen EN, Drevon CA, J Lipid Res 1988 29 1417 26 2853717 (Pubitemid 19013036)
17. Mode of action of peroxisome proliferators as hypolipidemic drugs. Hertz R, Bishara SJ, Bar TJ, J Biol Chem 1995 270 13470 75 7768950
18. Fatty acid-CoA thioesters are ligands of hepatic nuclear factor-4. Hertz R, Magenheim J, Berman I, Bar-Tana J, Nature 1998 392 512 16 10.1038/33185 9548258 (Pubitemid 28168984)
19. Regulatory potential of n-3 fatty acids in immunological and inflammatory processes. Grimm H, Mayer K, Mayser P, Eigenbrodt E, Br J Nutr 2002 87 Suppl 1 59 S67 11895155
20. The inhibition of T-lymphocyte proliferation is via an eicosanoid-independent mechanism. Calder PC, Bevan SJ, Newsholme EA, Immunology 1992 75 108 115 1537586
21. Cytokines in the generation and maturation of dendritic cells: Recent advances. Zou GM, Tam YK, Eur Cytokine Netw 2002 13 186 199 12101074 (Pubitemid 34747919)
22. Functional heterogeneity of colony-stimulating factor-induced human monocyte-derived macrophages. Akagawa KS, Komuro I, Kanazawa H, Yamazaki T, Mochida K, Kishi F, Respirology 2006 11 Suppl 32 S36 16423268
23. Role of the cytokine environment and cytokine receptor expression on the generation of functionally distinct dendritic cells from human monocytes. Conti L, Cardone M, Varano B, Puddu P, Belardelli F, Gessani S, Eur J Immunol 2008 38 750 762 10.1002/eji.200737395 18236400
24. +thymic selection in humans lacking ZAP-70 kinase. Arpaia E, Shahar M, Dadi H, Cohen A, Roifman CM, Cell 1994 76 947 958 10.1016/0092-8674(94)90368-9 8124727 (Pubitemid 24085331)
25. ZAP-70 deciency in an autosomal recessive form of severe combined immunodeciency. Chan AC, Kadlecek TA, Elder ME, Filipovich AH, Kuo WL, Iwashima M, Parslow TG, Weiss A, Science 1994 264 1599 1601 10.1126/science.8202713 8202713 (Pubitemid 24227717)
26. Human severe combined immunodeciency due to a defect in ZAP-70, a T cell tyrosine kinase. Elder ME, Lin D, Clever J, Chan AC, Hope TJ, Weiss A, Parslow TG, Science 1994 264 1596 1599 10.1126/science.8202712 8202712 (Pubitemid 24227716)
27. Essential role for ZAP-70 in both positive and negative selection of thymocytes. Negishi I, Motoyama N, Nakayama K, Nakayama K, Senju S, Hatakeyama S, Zhang Q, Chan AC, Loh DY, Nature 1995 376 435 438 10.1038/376435a0 7630421
28. Molecular basis for interaction of the protein-tyrosine kinase ZAP-70 with the T-cell receptor. Hatada MH, Lu X, Laird ER, Green J, Morgenstern JP, Lou M, Marr CS, Phillips TB, Ram MK, Theriault K, Nature 1995 377 32 38 10.1038/377032a0 7659156
29. Age-related impairments in TCR/CD3 activation of ZAP-70 are associated with reduced tyrosine phosphorylations of zeta-chains and p59fyn/p56lck in human T cells. Whisler RL, Chen M, Liu B, Newhouse YG, Mech Ageing Dev 1999 111 1 49 66 10.1016/S0047-6374(99)00074-3 10576607 (Pubitemid 29486436)
30. Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Mellor AL, Munn DH, Immunol 1999 20 469 473 (Pubitemid 29476077)
31. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. Hwu P, Du MX, Lapointe R, Do M, Taylor MW, Young HA, J Immunol 2000 164 3596 3599 10725715 (Pubitemid 30169812)
32. T cell proliferation is blocked by indoleamine 2,3-dioxygenase. Frumento G, Rotondo R, Tonetti M, Ferrara GB, Transplant Proc 2001 33 428 430 10.1016/S0041-1345(00)02078-9 11266894 (Pubitemid 32237450)
33. Inhibition of T cell proliferation by macrophage tryptophan catabolism. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL, J Exp Med 1999 189 1363 1372 10.1084/jem.189.9.1363 10224276 (Pubitemid 29227522)
34. Monocytes control gamma/delta T-cell responses by a secreted product. Okragly AJ, Hanby-Flarida M, Baldwin CL, Immunology 1995 86 599 605 8567027 (Pubitemid 26051812)
35. Interleukin-10 contributes development of macrophage suppressor activities by macrophage colony-stimulating factor, but not by granulocyte macrophage colony-stimulating factor. Mochida-Nishimura K, Akagawa KS, Rich EA, Cell Immunol 2001 214 81 88 10.1006/cimm.2001.1801 11902832 (Pubitemid 34280759)
36. 3+ T cells act as immune regulatory cells ex vivo. Hoek A, Rutten VP, Kool J, Arkesteijn GJ, Bouwstra RJ, Van Rhijn I, Koets AP, Vet Res 2009 40 06 10.1051/vetres:2008044
37. (+) regulatory T cells that are expanded at tumor sites. Camisaschi C, Casati C, Rini F, J Immunol 2010 184 11 6545 51 10.4049/jimmunol.0903879 20421648
38. Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system. Reiter RJ, Acũa-Castroviejo D, Tan DX, Burkhardt S, Ann N Y Acad Sci 2001 939 200 15 11462772 (Pubitemid 32620069)
39. Hypothalamic regulation of sleep and circadian rhythms. Saper CB, Scammell TE, Lu J, Nature 2005 437 1257 63 10.1038/nature04284 16251950 (Pubitemid 41568665)
40. Low levels of eicosapentaenoic and docosahexaenoic acids mimic the effects of fish oil upon rat lymphocytes. Peterson LD, Thies F, Sanderson P, Newsholme EA, Calder PC, Life Sci 1998 62 24 2209 17 10.1016/S0024-3205(98) 00199-4 9627080 (Pubitemid 28248438)
41. Diet, nutrition, and prostate cancer. Clinton SK, Giovannucci E, Annu Rev Nutr 1998 18 413 40 10.1146/annurev.nutr.18.1.413 9706231 (Pubitemid 28366874)
42. Inuence of n-3 fatty acid supplementation on the endogenous activities of plasma lipoprotein lipase. Harris WS, Lu GP, Rambjor GS, Walen AI, Ontko JA, Cheng Q, Windsor SL, Am J Clin Nutr 1997 66 254 60 9250102 (Pubitemid 27360322)
43. Fat cancer: the epidemiological evidence in perspective. Kolonel LN, Adv Exp Biol Med 1997 422 1 19 (Pubitemid 27479169)
44. The pathogenesis of atherosclerosis: a perspective for the 1990s. Ross R, Nature 1993 362 801 9 10.1038/362801a0 8479518 (Pubitemid 23132154)
45. Structural requirements for inhibition of cytokine-induced endothelial activation by unsaturated fatty acids. De CR, Bernini W, Carluccio MA, Liao JK, Libby P, J Lipid Res 1998 39 1062 70 9610774 (Pubitemid 28222012)
46. Endothelial-leukocyte adhesive interactions in inammatory diseases. Munro JM, European Heart Journal 1993 14 72S 77S
47. Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies. Tapiero H, Ba GN, Couvreur P, Tew KD, Biomed Pharmacother 2002 56 215 222 10.1016/S0753-3322(02)00193-2 12199620 (Pubitemid 35245217)
48. Docosahexaenoic acid regulated genes and transcription factors inducing apoptosis in human colon cancer cells. Narayanan BA, Narayanan NK, Reddy BS, Int J Oncol 2001 19 1255 1262 11713597
49. Frequent nitric oxide synthase-2-expression in human colon adenomas: implication for tumor angiogenesis in colon cancer progression. Ambs S, Merriam WG, Bennett WP, Felley-Bosco E, Ogunfusika MO, Oser SM, Klein S, Shields PG, Billiar TR, Harris CC, Cancer Res 1998 58 334 341 9443414 (Pubitemid 28047076)
50. Inflammatory citokines induce DNA damage and inhibit DNA repair in colonic carcinoma cells by a nitric oxide dependent mechanism. Jaiswal M, LaRusso NF, Burgart LJ, Gores GJ, Cancer Res 2000 60 184 189 10646872
51. Modulation of inducible nitric oxide synthase and related proinflammatory genes by the omega-3 fatty acid docosahexaenoic acid in human colon cancer cells. Narayanan BA, Narayanan NK, Simi B, Reddy BS, Cancer Res 2003 63 972 979 12615711 (Pubitemid 36278427)
52. Electrophilic cyclopentenone neuroprostanes are antiinflammatory mediators formed from the peroxidation of the omega-3 polyunsaturated fatty acid docosahexaenoic acid. Musiek ES, Brooks JD, Joo M, Brunoldi E, Porta A, Zanoni G, Vidari G, Blackwell TS, Montine TJ, Milne GL, McLaughlin B, Morrow JD, J Biol Chem 2008 283 19927 19935 10.1074/jbc.M803625200 18490445
53. Cyclopentenone isoprostanes inhibit the inflammatory response in macrophages. Musiek ES, Gao L, Milne GL, Han W, Everhart MB, Wang D, Backlund MG, DuBois RN, Zanoni G, Vidari G, Blackwell TS, Morrow JD, J Biol Chem 2005 280 35562 35570 10.1074/jbc.M504785200 16100121 (Pubitemid 41532748)
54. Unraveling lipid metabolism with microarrays: effects of arachidonate and docosahexaenoate acid on murine hepatic and hippocampal gene expression. Berger A, Mutch DM, German JB, Roberts MA, Genome Biol 2002 3 7 preprint0004
55. CSPG4 in Cancer: Multiple Roles. Wang X, Wang Y, Yu L, J Lipid Res 2011 52 2 263 71 10.1194/jlr.M011692 21115966
56. Melanoma growth is reduced in fat-1 transgenic mice: impact of omega-6/omega-3 essential fatty acids. Xia S, Lu Y, Wang J, He C, Hong S, Serhan CN, Kang JX, Proc Natl Acad Sci 2006 103 33 12499 504 10.1073/pnas.0605394103 16888035 (Pubitemid 44267287)
57. Suppressed liver tumorigenesis in fat-1 mice with elevated omega-3 fatty acids is associated with increased omega-3 derived lipid mediators and reduced TNF- Weylandt KH, Krause LF, Gomolka B, Chiu CY, Bilal S, Nadolny A, Waechter SF, Fischer A, Rothe M, Kang JX, Carcinogenesis 2011 32 6 897 903 10.1093/carcin/bgr049 21421544
58. Acute lung injury is reduced in fat-1 mice endogenously synthesizing n-3 fatty acids. Mayer K, Kiessling A, Ott J, Schaefer MB, Hecker M, Henneke I, Schulz R, Günther A, Wang J, Wu L, Roth J, Seeger W, Kang JX, Am J Respir Crit Care Med 2009 179 6 474 83 10.1164/rccm.200807-1064OC 19136374
59. Reduced colitis-associated colon cancer in Fat-1 (n-3 fatty acid desaturase) transgenic mice. Jia Q, Lupton JR, Smith R, Weeks BR, Callaway E, Davidson LA, Kim W, Fan YY, Yang P, Newman RA, Kang JX, McMurray DN, Chapkin RS, Cancer Res 2008 68 10 3985 91 10.1158/0008-5472.CAN-07-6251 18483285
60. Huntingtin-interacting protein 1-mediated neuronal cell death occurs through intrinsic apoptotic pathways and mitochondrial alterations. Shin AC, Steven JK, Kwang CC, FEBS Lett 2006 80 22 5275 82
61. Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival. Rao DS, Hyun TS, Kumar PD, Mizukami IF, Rubin MA, Lucas PC, Sanda MG, Ross TS, J Clin Invest 2002 110 351 360 12163454 (Pubitemid 34847967)
62. Folic acid and polyunsaturated fatty acids improve cognitive function and prevent depression, dementia, and Alzheimer's disease - but how and why? Prostaglandins Leukot. Das UN, Essent Fatty Acids 2008 78 11 19 10.1016/j.plefa.2007.10.006
63. A role for docosahexaenoic acidderived neuroprotectin D1 in neural cell survival and Alzheimer disease. Lukiw WJ, Cui JG, Marcheselli VL, Bodker M, Botkjaer A, Gotlinger K, Serhan CN, Bazan NG, J Clin Invest 2005 115 2774 2783 10.1172/JCI25420 16151530 (Pubitemid 41434404)
64. Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's. Calon F, Lim GP, Morihara T, Yang F, Ubeda O, Salem N Jr, Frautschy SA, Cole GM, Eur J Neurosci 2005 22 617 626 10.1111/j.1460-9568.2005.04253.x 16101743 (Pubitemid 41192272)
65. A striking organization of a large family of human neural cadherin-like cell adhesion genes. Wu Q, Maniatis T, Cell 1999 97 6 779 90 10.1016/S0092-8674(00)80789-8 10380929 (Pubitemid 29278051)
66. Recent advance and possible future in TREK-2: a two-pore potassium channel may involved in the process of NPP, brain ischemia and memory impairment. Huang D, Yu B, Med Hypotheses 2008 70 3 618 24 10.1016/j.mehy.2007. 06.016 17689202 (Pubitemid 351179897)
67. Semaphorin 5B mediates synapse elimination in hippocampal neurons. O'Connor TP, Cockburn K, Wang W, Tapia L, Currie E, Bamji SX, Neural Development 2009 4 18 10.1186/1749-8104-4-18 19463192
68. Improved spatial learning performance of fat-1 mice is associated with enhanced neurogenesis and neuritogenesis by docosahexaenoic acid. He C, Qu X, Cui L, Wang J, Kang JX, Proc Natl Acad Sci 2009 106 27 11370 11375 10.1073/pnas.0904835106 19549874
69. Gene and protein expression profiling of the fat-1 mouse brain. Ménesi D, Kitajka K, Molnár E, Kis Z, Belleger J, Narce M, Kang JX, Puskás LG, Das UN, Prostaglandins Leukot Essent Fatty Acids 2009 80 1 33 42 10.1016/j.plefa.2008.11.006 19138887
70. Transgenic conversion of omega-6 into omega-3 fatty acids in a mouse model of Parkinson's disease. Bousquet M, Gue K, Emond V, Julien P, Kang JX, Cicchetti F, Calon F, J Lipid Res 2011 52 2 263 71 10.1194/jlr.M011692 21115966
71. Docosahexaenoic acid promotes neurite growth in hippocampal neurons. Calderon F, Kim HY, J Neurochem 2004 90 4 979 88 10.1111/j.1471-4159.2004.02520. x 15287904 (Pubitemid 39099980)
72. Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival. Akbar M, Calderon F, Wen Z, Kim HY, Proc Natl Acad Sci 2005 102 10858 10863 10.1073/pnas.0502903102 16040805 (Pubitemid 41105957)
73. Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats. Hashimoto M, Tanabe Y, Fujii Y, Kikuta T, Shibata H, Shido O, J Nutr 2005 135 549 555 15735092 (Pubitemid 40365217)
74. Docosahexaenoic and eicosapentaenoic acids increase neuronal death in response to HuPrP82-146 and Abeta 1-42. Bate C, Marshall V, Colombo L, Diomede L, Salmona M, Williams A, Neuropharmacology 2008 54 934 943 10.1016/j. neuropharm.2008.02.003 18355880
75. Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells. Bate C, Tayebi M, Diomede L, Salmona M, Williams A, BMC Biol 2008 6 39 10.1186/1741-7007-6-39 18789130
76. The human olfactory receptor gene family. Malnic B, Godfrey PA, Buck LB, Proc Natl Acad Sci 2004 101 8 2584 9 10.1073/pnas.0307882100 14983052 (Pubitemid 38269354)
77. Septin expression in proliferative retinal membranes. Xin X, Pache M, Zieger B, Bartsch I, Prünte C, Flammer J, Meyer P, J Histochem Cytochem 2007 55 11 1089 94 10.1369/jhc.7A7188.2007 17625225 (Pubitemid 350006290)
78. Supranormal electroretinogram in fat-1 mice with retinas enriched in docosahexaenoic acid and n-3 very long chain fatty acids (C24-C36). Suh M, Sauvé Y, Merrells KJ, Kang JX, Ma DW, Invest Ophthalmol Vis Sci 2009 50 9 4394 401 10.1167/iovs.08-2565 19264893
79. Seminal leukocytes: passengers, terrorists or good samaritans? Aitken RJ, Baker HW, Hum Reprod 1995 10 1736 1739
80. Changes in sperm quality and lipid composition during cryopreservation of boar semen. Maldjian A, Pizzi F, Gliozzi T, Cerolini S, Penny P, Noble R, Theriogenology 2005 63 411 421 10.1016/j.theriogenology.2004.09.021 15626408 (Pubitemid 40033965)
81. Evaluation of the ratio of omega-6: omega-3 fatty acids and vitamin E levels in the diet on the reproductive performance of cockerels. Zanini SF, Torres CA, Bragagnolo N, Turatti JM, Silva MG, Zanini MS, Arch Tierernahr 2003 57 429 442 14982322
82. Calmegin is required for fertilin alpha/beta heterodimerization and sperm fertility. Ikawa M, Nakanishi T, Yamada S, Wada I, Kominami K, Tanaka H, Nozaki M, Nishimune Y, Okabe M, Dev Biol 2001 240 1 254 61 10.1006/dbio.2001.0462 11784061 (Pubitemid 33141122)
83. Genetic basis of endocrine disease 4. The spectrum of mutations in the androgen receptor gene that causes androgen resistance. McPhaul MJ, Marcelli M, Zoppi S, Griffin JE, Wilson JD, J Clin Endocrinol Metab 1993 76 17 23 10.1210/jc.76.1.17 8421085 (Pubitemid 23027545)
84. Androgen receptor transactivation domain and control of spermatogenesis. Yong EL, Ghadessy F, Wang Q, Mifsud A, Ng SC, Rev Reprod 1998 3 141 144 10.1530/ror.0.0030141 9829547 (Pubitemid 28508643)
85. SOX8 is expressed during testis differentiation in mice and synergizes with SF1 to activate the Amh promoter in vitro. Schepers G, Wilson M, Wilhelm D, Koopman P, J Biol Chem 2003 278 30 28101 8 10.1074/jbc.M304067200 12732652 (Pubitemid 36900007)